William J. Kullback

William J. Kullback has extensive experience in financial leadership, serving as Chief Financial Officer for multiple companies, including Telesis Bio (NASDAQ: TBIO), BioLegend, and Lombard Medical Technologies. Notably, William played a significant role at BioLegend during its acquisition by PerkinElmer (NYSE: PKI) for $5.25 billion in July 2021. Additional roles include CFO and Chief Compliance Officer at CoastEdge Partners, LLC. William J. Kullback holds both a Bachelor’s and a Master’s degree in Accounting and Finance from the University at Buffalo, completed between 1978 and 1984.